GlassScriptPhysician profile
Hanna Afeworki
NPI 1780862508
$1,040.50
in general payments reported to CMS, 2019-2025
16 companies · $233 in 2025
The $233 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $103 · 2021: $167 · 2022: $57.46 · 2023: $150 · 2024: $164 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $307.01 | 2020-2025 | Doc Band |
| Glaxosmithkline, LLC. | $186.60 | 2019-2024 | Pediarix, Menveo, Bexsero |
| Sanofi Pasteur INC. | $134.93 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.04 | 2021 | |
| Sanofi-Aventis U.S. LLC | $72.54 | 2025 | |
| Pfizer INC. | $46.93 | 2020-2025 | |
| Shire North American Group INC | $44.94 | 2019 | |
| Seqirus USA INC | $33.01 | 2023-2024 | Flucelvax Quadrivalent, Flucelvax |
| Aimmune Therapeutics, INC. | $21.11 | 2023 | |
| Phadia US INC. | $19.67 | 2025 | Immunocap |
| Neos Therapeutics, LP | $17.05 | 2021 | |
| Sobi, INC | $16.26 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.22 | 2025 | Zoryve |
| Amneal Pharmaceuticals LLC | $14.06 | 2019 | |
| Merck Sharp & Dohme LLC | $13.31 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hanna Afeworki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.